Browse studies

Find your next paid study

1 recruiting study matching your filters

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE849 in Patients With DLL3-Expressing Tumors Including Small Cell Lung Cancer

This is Phase 1/2, multicenter, clinical study to evaluate the safety, efficacy, PK, and immunogenicity of IDE849 in subjects with DLL3-expressing tumors inclu…

Small-cell Lung CancerNeuroendocrine CarcinomasSolid Tumor Show to Express DLL3

IDEAYA BiosciencesNCT07174583